Advanced Search
Contact | Corporate | Help

Paclitaxel + Bevacizumab (Avastin®) for the Treatment of Metastatic or Unresectable Angiosarcoma

Sponsors:
  • Stanford University
  • Genentech
Phases:
  • Phase II
IndicationsAcronym:
  • Hemangiosarcoma
Age Groups:
  • Child
  • Adult
  • Senior
Gender:
Both
Names:
  • Drug: Paclitaxel in combination with Bevacizumab
Enrollment:
20

Additional information about NCT01055028.


SourceSolution © 2008-2012